Atlas Trials

T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas

Clinical trial NCT07447531 · RECRUITING

Trial details

NCT number
NCT07447531
Sponsor
John M. Buatti
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Malignant Glioma
Start date
2025-10-03
Primary completion
2028-10-06
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.